ArticlebioRxiv : the preprint server for biology2026
Leveraging Lineage Barcodes as Natural Augmentations for Contrastive Learning of Cell Fate in scRNA-seq Data.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Deciphering how cells commit to future fates is essential for developing precision therapeutics that can reprogram stem cells or modulate immune functions. However, isolating these fate-determining signals in single-cell lineage tracing (scLT) remains challenging because differentiation programs are often confounded by unrelated processes like the cell cycle. To address this, we introduce Lineage-aware Contrastive Learning (LCL), a framework that treats inheritable lineage barcodes as a "natural" data augmentation to isolate subtle, lineage-specific signals. LCL utilizes a semi-supervised architecture to align unlabeled cells, facilitating the transfer of lineage structures to clinical datasets where explicit barcoding is unavailable. We demonstrate LCL's utility by predicting future cell-type compositions from early-time points, effectively modeling longitudinal fate commitment from cross-sectional data. Benchmarking on hematopoietic and fibroblast systems shows that LCL significantly outperforms standard models like scVI, establishing contrastive learning as a scalable paradigm for understanding and potentially manipulating cellular differentiation.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.